- Home
- MNTK vs AUTL Comparison
MNTK vs AUTL Comparison
Compare MNTK & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- AUTL
- Stock Information
- Founded
- MNTK 1980
- AUTL 2014
- Country
- MNTK United States
- AUTL United Kingdom
- Employees
- MNTK N/A
- AUTL N/A
- Industry
- MNTK Natural Gas Distribution
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNTK Utilities
- AUTL Health Care
- Exchange
- MNTK Nasdaq
- AUTL Nasdaq
- Market Cap
- MNTK 622.2M
- AUTL 590.8M
- IPO Year
- MNTK 2021
- AUTL 2018
- Fundamental
- Price
- MNTK $4.51
- AUTL $2.37
- Analyst Decision
- MNTK Hold
- AUTL Strong Buy
- Analyst Count
- MNTK 2
- AUTL 3
- Target Price
- MNTK $6.00
- AUTL $10.20
- AVG Volume (30 Days)
- MNTK 164.7K
- AUTL 1.2M
- Earning Date
- MNTK 03-13-2025
- AUTL 03-13-2025
- Dividend Yield
- MNTK N/A
- AUTL N/A
- EPS Growth
- MNTK 42.11
- AUTL N/A
- EPS
- MNTK 0.16
- AUTL N/A
- Revenue
- MNTK $194,849,000.00
- AUTL $10,091,000.00
- Revenue This Year
- MNTK $21.28
- AUTL $851.83
- Revenue Next Year
- MNTK $31.59
- AUTL $264.18
- P/E Ratio
- MNTK $28.44
- AUTL N/A
- Revenue Growth
- MNTK 9.63
- AUTL 82.71
- 52 Week Low
- MNTK $3.38
- AUTL $2.07
- 52 Week High
- MNTK $7.75
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- MNTK 56.40
- AUTL 46.88
- Support Level
- MNTK $4.18
- AUTL $2.12
- Resistance Level
- MNTK $4.24
- AUTL $2.38
- Average True Range (ATR)
- MNTK 0.25
- AUTL 0.13
- MACD
- MNTK 0.04
- AUTL 0.02
- Stochastic Oscillator
- MNTK 60.00
- AUTL 37.23
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.